Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 EirGenix Opens Mfg. Plant in Taiwan | Contract Pharma

What are you searching for?

Sign in
Breaking News

EirGenix Opens Mfg. Plant in Taiwan

Also inks ADC deal with Oncomatryx Biopharma

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

EirGenix, a contract development and manufacturing organization (CDMO) and a biosimilars maker, has opened a new protein production facility at the Hsinchu Biomedical Park in Zubei, Taiwan, boosting its CDMO capabilities. 
 
In addition to the new facility, the company, together with its parent, Formosa Labs, signed an agreement with Spain’s Oncomatryx Biopharma for the development of new antibody drug conjugates (ADCs). 
 
Since its formation in December 2012, EirGenix has completed more than 10 CDMO projects for overseas customers. It also operates a subsidiary, Formosa Pharmaceuticals, which offers new drug development services. It is currently building an injectable manufacturing plant with the goal of being a one-stop-shop from API manufacturing to drug product filling.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics